scanX
Biocon
add_icon

Biocon

427.40
+1.40
(0.33%)
Market Cap
69,277.60 Cr
PE Ratio
167.97
Volume
34,76,631.00
Day High - Low
430.50 - 422.60
52W High-Low
447.15 - 331.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
69,277.60 Cr
EPS
2.82
PE Ratio
167.97
PB Ratio
2.03
Book Value
211.51
EBITDA
3,797.80
Dividend Yield
0.12 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
1.01
Debt to Equity
0.61
Analyst Rating and Forecast
- By Refinitiv from16 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+43.75 %
+43.75 %
Hold
Hold+18.75 %
+18.75 %
Sell
Sell+37.50 %
+37.50 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Biocon to host analysts at Emkay Confluence 20264 days ago
Biocon Limited will participate in a virtual group meeting with analysts and institutional investors on August 12, 2026, as part of the Emkay Confluence 2026 event.
negative
Biocon Q1 Results: Mixed Analyst Views, EBITDA Margin at 25.5%5 days ago
Brokerages split on Biocon after Q1FY27 miss; revenue up 10% on currency tailwinds, biosimilar CC growth only 5%, EBITDA margin at 25.5%. Targets range from ₹326 to ₹490.
neutral
Biocon Biologics auditor resigns to align with parent5 days ago
B S R & Co. LLP resigns as statutory auditor of Biocon Biologics Limited effective August 6, 2026, citing mandatory rotation at parent company Biocon Limited.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,933.00
#1 4,63,791.45
38.42
#1 61,673.90
12.69
#1 11,565
26.53
51.03
Divis Laboratories
8,484.50
2,25,236.82
77.48
11,067.00
13.95
2,568
65.50
77.55
Torrent Pharmaceuticals
4,890.00
1,85,999.88
85.88
13,886.20
20.34
2,138
3.28
49.07
Zydus Life Science
1,201.00
1,20,848.70
25.63
27,657.90
17.64
5,026
-34.90
68.32
Cipla
1,462.50
1,18,147.38
35.19
29,044.60
2.24
3,870
-39.18
55.73
Lupin
2,259.90
1,03,329.98
#1 18.76
29,038.90
#1 26.75
5,356
16.00
33.95
Dr Reddys Laboratories
1,199.60
1,00,126.90
31.59
35,058.60
3.90
4,158
-69.10
50.59
Mankind Pharma
2,423.00
1,00,068.93
48.44
14,636.40
14.85
1,938
29.13
42.12
Laurus Labs
1,845.30
99,619.74
92.17
6,867.80
22.01
890
#1 123.93
79.87
Aurobindo Pharma
1,657.80
95,386.15
25.70
34,145.20
5.56
3,503
25.21
64.42
Growth Rate
Revenue Growth
4.85 %
Net Income Growth
-74.20 %
Cash Flow Change
-50.90 %
ROE
-80.43 %
ROCE
-53.67 %
EBITDA Margin (Avg.)
-17.21 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
952
778
800
811
1,223
1,029
989
1,086
974
986
1,025
1,098
1,242
1,193
1,564
1,585
1,557
1,483
1,673
1,784
1,621
1,712
1,765
1,885
2,060
1,808
1,945
2,223
2,476
2,217
2,384
3,020
3,929
3,516
3,551
4,135
3,912
4,543
3,604
3,826
4,415
3,990
4,356
4,240
4,537
4,346
Expenses
653
606
727
615
740
719
706
762
738
735
786
836
937
886
982
1,160
1,137
1,029
1,174
1,307
1,247
1,284
1,363
1,459
1,476
1,427
1,515
1,733
1,911
1,783
1,894
2,624
2,820
2,741
2,769
3,051
3,013
2,813
2,905
3,070
3,339
3,193
3,472
3,633
3,577
3,502
EBITDA
300
172
73
196
483
309
283
324
236
250
239
262
306
307
582
425
420
454
499
477
373
428
402
427
584
380
430
489
565
434
490
396
1,109
775
782
1,084
900
1,730
699
756
1,077
797
884
607
960
844
Operating Profit %
21 %
20 %
6 %
22 %
21 %
27 %
25 %
27 %
20 %
21 %
19 %
21 %
20 %
21 %
26 %
25 %
26 %
29 %
25 %
25 %
20 %
24 %
22 %
21 %
20 %
19 %
18 %
20 %
21 %
17 %
18 %
11 %
25 %
20 %
18 %
14 %
22 %
17 %
18 %
19 %
23 %
18 %
19 %
12 %
20 %
18 %
Depreciation
59
59
61
64
65
66
68
70
73
99
94
97
95
99
112
117
120
124
132
144
152
167
178
186
184
195
202
206
212
218
231
301
364
358
389
415
407
405
420
425
436
455
473
515
513
547
Interest
0
4
3
2
21
6
7
9
5
16
14
15
17
18
19
19
16
17
14
18
17
13
7
5
34
20
23
15
11
20
30
120
249
233
248
267
227
236
226
223
212
277
272
210
232
213
Profit Before Tax
249
165
20
141
409
238
208
245
159
135
132
150
193
190
451
289
284
313
354
315
204
249
218
236
366
166
206
269
343
197
229
-26
497
184
214
808
319
1,146
98
156
487
97
171
-68
248
128
Tax
32
34
18
19
55
55
42
54
10
38
43
36
41
52
73
46
41
85
100
85
45
81
22
49
69
57
46
49
59
30
147
-5
82
35
42
55
96
284
71
75
27
8
39
-16
49
-9
Net Profit
217
131
2
122
354
182
167
191
148
98
89
114
153
138
378
243
243
228
254
230
159
168
195
187
296
108
160
220
284
167
82
-21
415
149
173
753
223
862
27
81
459
89
133
-52
199
137
EPS in ₹
10.08
6.31
-0.54
5.30
16.97
8.49
7.48
8.72
6.49
1.38
1.17
1.56
2.21
1.02
3.00
3.67
3.61
1.74
1.82
1.71
1.04
1.26
1.39
1.42
2.13
0.71
1.16
1.57
2.00
1.21
0.39
-0.35
2.62
0.85
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
1.08
0.79
0.87
Above figures are in Rs. Crores

Order Value Trend

FY 2026-27 order value₹225.00 Cr
FY 2026-271 Orders
Ministry of Health (MoH), Mala...
100.00%

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
6,375
8,458
9,394
9,990
12,192
14,444
18,522
20,394
52,043
56,071
58,797
63,651
Fixed Assets
1,630
1,749
3,626
3,700
4,471
5,971
6,364
6,569
29,468
30,644
31,963
36,486
Current Assets
2,563
3,971
4,048
4,149
4,889
5,325
7,600
8,382
12,334
15,179
16,286
17,180
Capital Work in Progress
1,677
2,240
839
1,303
1,899
2,196
2,800
4,110
7,317
7,993
8,508
6,987
Investments
230
901
1,253
675
1,012
966
1,952
1,588
2,069
1,000
1,127
1,779
Other Assets
2,839
3,569
3,676
4,312
4,811
5,311
7,406
8,127
13,189
16,434
17,199
18,399
Total Equity & Liabilities
6,375
8,458
9,394
9,990
12,192
14,444
18,522
20,394
52,043
56,071
58,797
63,651
Current Liabilities
1,555
1,666
1,678
2,141
3,039
4,008
4,210
3,828
8,511
15,359
14,334
14,069
Non Current Liabilities
1,378
2,493
2,502
2,200
2,447
3,053
5,805
7,096
21,043
15,437
16,751
12,960
Total Equity
3,443
4,300
5,214
5,649
6,707
7,383
8,508
9,470
22,489
25,275
27,713
36,622
Reserve & Surplus
3,171
3,992
4,738
4,881
5,798
6,106
7,027
7,832
17,267
19,183
21,122
33,329
Share Capital
100
100
100
300
300
600
600
600
600
600
600
811
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-94
300
-47
-261
210
165
72
-243
641
-380
2,004
-812
Investing Activities
-491
-1,138
-510
-684
-703
-1,505
-3,651
-1,662
-14,260
-1,002
-203
-1,883
Operating Activities
211
371
640
662
1,155
1,283
1,160
1,177
1,853
2,954
4,061
1,994
Financing Activities
186
1,068
-178
-240
-242
388
2,564
242
13,049
-2,333
-1,854
-924
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Jan 2026
Mar 2026
Jun 2026
Promoter
60.67 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
54.45 %
54.45 %
54.45 %
44.91 %
44.91 %
44.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
7.96 %
6.55 %
5.63 %
5.90 %
5.93 %
5.66 %
5.66 %
6.04 %
6.61 %
7.39 %
7.14 %
7.52 %
8.14 %
DIIs
6.65 %
6.89 %
6.87 %
6.83 %
7.79 %
7.30 %
7.76 %
8.63 %
11.90 %
12.56 %
14.08 %
14.51 %
13.68 %
14.30 %
14.44 %
15.37 %
15.72 %
22.82 %
22.10 %
21.71 %
24.16 %
24.07 %
23.38 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.89 %
11.03 %
11.49 %
11.37 %
10.87 %
10.72 %
12.07 %
12.46 %
13.21 %
13.34 %
13.61 %
14.47 %
15.53 %
14.63 %
14.57 %
14.07 %
13.63 %
12.58 %
12.71 %
12.38 %
10.23 %
10.01 %
10.26 %
Others
21.79 %
21.44 %
21.00 %
21.16 %
20.70 %
21.35 %
19.54 %
18.27 %
14.26 %
13.46 %
3.70 %
3.83 %
4.52 %
4.53 %
4.42 %
4.27 %
4.34 %
4.10 %
4.12 %
4.06 %
13.55 %
13.49 %
13.54 %
No of Share Holders
0
3,11,349
3,38,815
3,63,447
3,64,502
3,47,911
3,41,016
3,69,816
4,11,086
4,12,441
4,15,046
4,34,339
4,70,261
4,43,513
4,39,503
4,27,705
4,24,297
4,30,217
4,13,191
3,94,279
3,94,215
3,86,593
3,92,509

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 3 1 1 0.00 0.00 0.5 1.5 0.5 0.5 0.5
Dividend Yield (%) 1.01 0.33 0.37 0.00 0.00 0.25 0.57 0.15 0.14 0.12

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Jun 2019 BONUS Bonus
1:1
 12 Jun 2019 271.45 257.90
01 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
 30 Jun 2022 382.30 308.40
07 Jul 2023 DIVIDEND Dividend
₹ 1.50 /share
 07 Jul 2023 240.45 259.50
05 Jul 2024 DIVIDEND Dividend
₹ 0.50 /share
 05 Jul 2024 311.90 361.10
09 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 09 Aug 2024 311.90 339.20
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Oct 2024 370.65 326.85
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 372.95 355.70
08 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 08 May 2025 339.10 346.50
04 Jul 2025 DIVIDEND Dividend
₹ 0.50 /share
 04 Jul 2025 346.50 374.40
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 Aug 2025 372.05 360.60
08 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 08 Aug 2025 346.50 364.20
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Nov 2025 352.25 382.15
31 Dec 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 31 Dec 2026 392.80 390.40
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Feb 2026 371.80 375.80
07 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 May 2026 357.80 380.75
03 Jul 2026 DIVIDEND Dividend
₹ 0.50 /share
 03 Jul 2026 380.75 418.60
05 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Aug 2026 436.05 425.15
06 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 06 Aug 2026 415.50 425.20

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation19 hrs ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript19 hrs ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors5 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate5 days ago
Completion Of Tenure Of Statutory Auditors5 days ago
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s5 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate5 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation6 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release6 days ago
Board Meeting Outcome for Outcome Of Board Meeting6 days ago
Outcome Of Board Meeting-Financial Results6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
Commercial Launch Of Product9 days ago
Company StatementJul 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2026
Board Meeting Intimation for Intimation For The Board Meeting And Earnings Conference Call For Analysts And InvestorsJul 28, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2026
Company StatementJul 16, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jul 15, 2026
Reg. 34 (1) Annual Report.Jul 15, 2026
48Th Annual General Meeting For Financial Year 2025 - 26 To Be Held On Thursday August 06 2026Jul 15, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 07, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJun 29, 2026
Announcement under Regulation 30 (LODR)-AllotmentJun 29, 2026
Closure of Trading WindowJun 27, 2026
Closure of Trading WindowJun 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 24, 2026
Communication To The Shareholders W.R.T. TDS On Final DividendJun 22, 2026
Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 08, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJun 01, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2026
Reminder Letter To Shareholders To Claim Unclaimed DividendsMay 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 14, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Active Momentum Fund Direct-Growth
0.00%
-1159906
-2.34%
-2.39%
ICICI Prudential Quality Fund Direct-Growth
0.95%
480644
0.95%
0.95%
HDFC Innovation Fund Direct-Growth
1.24%
365098
0.48%
0.44%
Helios Arbitrage Fund Direct-Growth
0.00%
-100000
-2.86%
-2.98%
TRUSTMF Mid Cap Fund Direct-Growth
0.98%
98975
0.98%
0.98%
The Wealth Company Multi Asset Allocation Fund Direct-Growth
0.00%
-78220
-1.74%
-1.08%
Quant Arbitrage Fund Direct-Growth
0.00%
-50000
-0.38%
-0.53%
JioBlackRock Arbitrage Fund Direct-Growth
0.00%
-50000
-0.37%
0.00%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-47031
-0.73%
-0.76%
TRUSTMF Large & Mid Cap Fund Direct-Growth
0.55%
36520
0.55%
0.55%
Old Bridge Arbitrage Fund Direct-Growth
0.00%
-27500
-0.61%
-0.43%
The Wealth Company Arbitrage Fund Direct-Growth
2.16%
25000
0.49%
0.63%
Unifi Dynamic Asset Allocation Fund Direct-Growth
0.00%
-22500
-0.07%
-0.08%
WhiteOak Capital Equity Savings Fund Direct-Growth
1.23%
15000
-0.59%
0.30%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-9661
-0.25%
-0.23%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.73%
2513
-0.01%
-0.03%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-2151
-0.14%
-0.16%
The Wealth Company Small Cap Fund Direct-Growth
1.77%
1000
-0.28%
0.73%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.25%
-465
-0.01%
0.04%
DSP Nifty Healthcare Index Fund Direct-Growth
2.64%
398
-0.10%
-0.29%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
0.73%
335
0.00%
-0.03%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.25%
218
0.00%
-0.02%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.37%
195
0.00%
-0.01%
Groww Nifty Midcap 150 Index Fund Direct-Growth
0.73%
-97
0.00%
-0.03%
DSP Nifty Midcap 150 Index Fund Direct-Growth
0.73%
95
0.00%
-0.03%

Technical Indicators

RSI(14)
Neutral
49.37
ATR(14)
Less Volatile
10.13
STOCH(9,6)
Neutral
28.15
STOCH RSI(14)
Neutral
24.28
MACD(12,26)
Bearish
-1.19
ADX(14)
Weak Trend
14.63
UO(9)
Bearish
51.46
ROC(12)
Downtrend And Accelerating
-1.76
WillR(14)
Neutral
-74.32
Bearish
5
Neutral
4
Bullish
0

About Biocon

Biocon Limited is India's largest fully-integrated biopharmaceutical company, focusing on biotechnology products and research services. Founded in 1978, Biocon specializes in treating diabetes, cancer, and autoimmune diseases. The company develops and commercializes novel biologics, biosimilars, complex small molecule APIs, and generic formulations for global markets. Biocon's product portfolio includes cardiology,...more
Listing Date
07 Apr, 2004(22 Years, 4 Months, 5 Days)
Website
https://www.biocon.com
Chairperson NameKiran Mazumdar Shaw
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104